AnHorn 安宏生醫
Innovative therapeutics targeting disease-causing proteins using proprietary drug discovery platform AIMCADD. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD55—82m (Dealroom.co estimates Apr 2023.)
台北市 Taiwan (HQ)
Authorizing premium user...